View the Published
Tutivia™ Validation Study
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Press Releases
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
ATC Presentation 2024
Downloadable Documents
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
ATC Presentation 2024
Downloadable Documents
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Press Releases
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
Tutivia™ Draw, Process, and Shipping Video
Recent News
Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026
Coffee & Cases Episode 6: The Impact of Restricting Out-of-Sequence Allocation in the U.S
Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients
Archived News
© 2026 VericiDx
Privacy Policy
|
Clinical Trials Privacy Policy
|
Cookie Policy
Search for:
close
chevron-down
linkedin-square
bars
cross
menu
chevron-down
